Ammann, R., Bodmer, N., Hirt, A., Niggli, F., Nadal, D., Simon, A., Ozsahin, H., Kontny, U.,
Kuhne, T., Popovic, M., Luthy, A. and Aebi, C. ,2010. Predicting Adverse Events in
Children With Fever and Chemotherapy-Induced Neutropenia: The Prospective Multicenter
SPOG 2003 FN Study. Journal of Clinical Oncology, 28(12), pp.2008-2014.
Asturias, E., Quezada, J. and Corral, J., 2010. Evaluation of six risk factors for the development of
bacteremia in children with cancer and febrile neutropenia. Current Oncology, 17(2).
Bhatt, Varsha, and Abdus Saleem. "Druginduced Neutropenia – Pathophysiology, Clinical Features,
And Management". Annals of Clinical & Laboratory Science vol. 34.no. 2 (2004): 131-137.
Web. 21 Sept. 2015.
Boxer, L ., Walkovich, K. , 2013. How to Approach Neutropenia in Childhood. Pediatrics in
Review, 34(4), pp.173-184.
Braden, C.D 2004. Neutropenia. Available at: http://emedicine.medscape.com/article/204821-
overview#aw2aab6b2b4aa [Accessed 6 June 2018].
Castagnola, E., Garrè, M., Bertoluzzo, L., Pignatelli, S., Pavanello, M., Caviglia, I., Caruso, S.,
Bagnasco, F., Moroni, C., Tacchella, A. and Haupt, R. (2011). Epidemiology of Febrile
Neutropenia in Children With Central Nervous System Tumor. Journal of Pediatric
Hematology/Oncology, 33(7), pp.e310-e315.
Crawford, J., Dale, D. and Lyman, G. ,2004. Chemotherapy-induced neutropenia: risks,
consequences, and new directions for its management.Cancer. (2004) 100(2):228-37.
Cancer, 100(9), pp.1993-1994.
Dale, D. and Lyman, G. ,2009. Chemotherapy-induced neutropenia: risks, consequences, and new
directions for its management.Cancer. (2004) 100(2):228-37. Cancer, 100(9), pp.1993-1994.
Freifeld, A., Bow, E., Sepkowitz, K., Boeckh, M., Ito, J., Mullen, C., Raad, I., Rolston, K., Young,
J. and Wingard, J. ,2011. Clinical Practice Guideline for the Use of Antimicrobial Agents in
Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of
America. Clinical Infectious Diseases, 52(4), pp.e56-e93.
Hassan, B. A.Rasool , Mohd Yusoff Z B , Othman .S., 2010.Clinical Signs and Association with
Neutropenia in Solid Cancer Patients - Bacterial Infection as the Main Cause. Asian Pacific
Journal of Cancer Prevention, Vol 11.
Lehrnbecher, T., Phillips, R., Alexander, S., Alvaro, F., Carlesse, F., Fisher, B., Hakim, H.,
Santolaya, M., Castagnola, E., Davis, B., Dupuis, L., Gibson, F., Groll, A., Gaur, A., Gupta,
A., Kebudi, R., Petrilli, S., Steinbach, W., Villarroel, M., Zaoutis, T. and Sung, L. ,2012.
Guideline for the Management of Fever and Neutropenia in Children With Cancer and/or
Undergoing Hematopoietic Stem-Cell Transplantation. Journal of Clinical Oncology,
30(35), pp.4427-4438.
Lyman, G. (2005). Risk Models for Predicting Chemotherapy-Induced Neutropenia. The Oncologist,
10(6), pp.427-437.
Lyman, G., Abella, E. and Pettengell, R. ,2014. Risk factors for febrile neutropenia among patients
with cancer receiving chemotherapy: A systematic review. Critical Reviews in
Oncology/Hematology, 90(3), pp.190-199.
Marinella . M., 2015. Fever in Patients with Cancer - Infectious Disease and Antimicrobial
Agents.Antimicrobe.org. Available at: http://www.antimicrobe.org/new/e13.asp#t1
[Accessed 6 June 2018].
Pizzo PA. Fever in immunocompromised patients. N Eng J Med 1999; 341:893-9.
Schouten, H. ,2006. Neutropenia management. Annals of Oncology, 17(suppl 10), pp.x85-x89.
Segel, G. and Halterman, J. ,2008. Neutropenia in Pediatric Practice. Pediatrics in Review, 29(1),
pp.12-24.